All stock lists
NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
Healthcare · Biotechnology
1.22-0.15 (-10.95%)
Market cap
$142M
Website
Insider Score
––Not scored
NBP Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
NBP Income Statement
| Fiscal Period | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Period Ending | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| SG&A Expense | 17.24 M | 5.81 M | 3.82 M | 4.49 M |
| R&D Expense | 55.66 M | 3.18 M | 3.29 M | 777.00 K |
| Operating Expenses | 72.90 M | 8.99 M | 7.11 M | 5.27 M |
| Operating Income | -72.90 M | -8.99 M | -7.11 M | -5.27 M |
| Pretax Income | -72.86 M | -6.83 M | -5.50 M | -3.15 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -30.79 M | -6.83 M | -5.50 M | -3.15 M |
| EPS (Basic) | — | — | -0.07 | -0.05 |
| EPS (Diluted) | — | — | -0.07 | -0.05 |
| Shares Outstanding | — | — | 81.70 M | 81.60 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.